Showing results (641-650 of 938) with videos related to
Sort By:
Pageof 94
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of ratsS Rose, S Hunt, P Collins, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic studyB Y Zeng, R K Pearce, G M MacKenzie, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus)E C Maratos, M J Jackson, R K Pearce, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2013
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosetsM J Jackson, T Swart, R K B Pearce, et al.Neuroscience|March 8, 2002
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegenerationM M Iravani, K Kashefi, P Mander, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2002
The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administrationL A Smith, M J Jackson, G Al-Barghouthy, et al.Leprosy Review|June 1, 1992
Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agentsS G Franzblau, A N Biswas, P Jenner, et al.Journal of Neurochemistry|May 1, 1997
An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's diseaseL Lyras, N J Cairns, A Jenner, et al.The European Journal of Neuroscience|April 13, 2000
Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPAB Y Zeng, R K Pearce, G M MacKenzie, et al.Brain : a Journal of Neurology|April 1, 1997
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET studyA O Ceballos-Baumann, G Sheean, R E Passingham, et al.Pageof 94